{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:16:33Z","timestamp":1785539793318,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euf.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:19:28Z","timestamp":1775823568000},"page":"325-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Making the Most of Pharmacologic Interventions: Urodynamic Effects of Different Therapies for Neurogenic Lower Urinary Tract Dysfunction Following Spinal Cord Injury"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-5885","authenticated-orcid":false,"given":"Bridget Lang","family":"Findlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.03.011_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/nau.25369","article-title":"Bladder management is the top health concern among adults with a spinal cord injury","volume":"43","author":"Loftus","year":"2024","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2026.03.011_b0010","unstructured":"Blok B, Hamid R, Hentzen C, et al. EAU guidelines on neurourology, https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Neuro-Urology-2026.pdf."},{"key":"10.1016\/j.euf.2026.03.011_b0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/JU.0000000000002239","article-title":"The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.03.011_b0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.03.011_b0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/nau.20289","article-title":"Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage","volume":"25","author":"Horstmann","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2026.03.011_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40272-017-0249-x","article-title":"Pharmacotherapy for pediatric neurogenic bladder","volume":"19","author":"Kroll","year":"2017","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.euf.2026.03.011_b0035","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1089\/neu.2022.0333","article-title":"Fesoterodine ameliorates autonomic dysreflexia while improving lower urinary tract function and urinary incontinence-related quality of life in individuals with spinal cord injury: a prospective Phase IIa study","volume":"40","author":"Walter","year":"2023","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.euf.2026.03.011_b0040","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/nau.70136","article-title":"Comparison of the efficacy of vibegron and fesoterodine for neurogenic detrusor overactivity in individuals with spinal cord lesion: a single-center prospective randomized crossover trial","volume":"44","author":"Takahashi","year":"2025","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2026.03.011_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/iju.iju_352_23","article-title":"The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: a narrative review","volume":"40","author":"Welk","year":"2024","journal-title":"Indian J Urol"},{"key":"10.1016\/j.euf.2026.03.011_b0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41393-022-00853-3","article-title":"Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review","volume":"60","author":"Akkoc","year":"2022","journal-title":"Spinal Cord"},{"key":"10.1016\/j.euf.2026.03.011_b0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5213\/inj.2550050.025","article-title":"A prospective paired comparison trial of mirabegron and anticholinergics in patients with low bladder compliance","volume":"29","author":"Son","year":"2025","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.euf.2026.03.011_b0060","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/nau.22376","article-title":"OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity","volume":"32","author":"Rovner","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2026.03.011_b0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2012.11.010","article-title":"Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis","volume":"81","author":"Kennelly","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.03.011_b0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.17219\/acem\/90764","article-title":"How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinA","volume":"28","author":"Przydacz","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.euf.2026.03.011_b0075","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:29:44Z","timestamp":1785529784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2405456926000490"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.03.011","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Making the Most of Pharmacologic Interventions: Urodynamic Effects of Different Therapies for Neurogenic Lower Urinary Tract Dysfunction Following Spinal Cord Injury","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}